Prevpac

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved February 1999

Specific Treatments:

Gastroenterology

Therapeutic Areas

General Information

Prevpac (lansoprazole, clarithromycin and amoxicillin), Rx, has been approved for the eradication of H. pylori to reduce the risk of duodenal ulcer recurrence. This efficacy supplement changed the duration of treatment with lansoprazole from 14 to 10 days and included recent minor changes to the clarithromycin labeling.